By creating bioanalytical assays that are more convenient to patients, bioanalytical scientists can propel drug development and potentially improve clinical trial recruitment and compliance. Attendees will learn how bioanalytical and clinical teams can work together to create sampling paradigms that are tailored to specific patient population without compromising assay integrity. A review of matrices, new techniques, and regulatory requirements relevant to these unique sampling approaches will be presented.
Learning Objectives:
Understand the advantages of patient centric sampling and what patient centric sampling entails
Discover strategies and goals for collaboration between bioanalytical and clinical teams to develop patient centric sampling
Appreciate and plan for additional testing that may be required during method development and assay validation
